Norepinephrine Genes Predict Response Time Variability and Methylphenidate-Induced Changes in Neuropsychological Function in Attention Deficit Hyperactivity Disorder
Authors:
- Jae-Won KimJKJae-Won Kim
- Tarrant D.R. CumminsTCTarrant D.R. Cummins
- Mark A. BellgroveMBMark A. Bellgrove
- Ziarih HawiZHZiarih Hawi
- Soon-Beom HongSHSoon-Beom Hong
- Young-Hui YangYYYoung-Hui Yang
- Hyo-Jin KimHKHyo-Jin Kim
- Min-Sup ShinMSMin-Sup Shin
- Soo-Churl ChoSCSoo-Churl Cho
- Ji-Hoon KimJKJi-Hoon Kim
- Jung-Woo SonJSJung-Woo Son
- 1 June 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 33 (3) , 356-362
Abstract
Noradrenergic dysfunction may be associated with cognitive impairments in attention-deficit/hyperactivity disorder (ADHD), including increased response time variability, which has been proposed as a leading endophenotype for ADHD. The aim of this study was to examine the relationship between polymorphisms in the α-2A-adrenergic receptor (ADRA2A) and norepinephrine transporter (SLC6A2) genes and attentional performance in ADHD children before and after pharmacological treatment.One hundred one medication-naive ADHD children were included. All subjects were administered methylphenidate (MPH)-OROS for 12 weeks. The subjects underwent a computerized comprehensive attention test to measure the response time variability at baseline before MPH treatment and after 12 weeks. Additive regression analyses controlling for ADHD symptom severity, age, sex, IQ, and final dose of MPH examined the association between response time variability on the comprehensive attention test measures and allelic variations in single-nucleotide polymorphisms of the ADRA2A and SLC6A2 before and after MPH treatment.Increasing possession of an A allele at the G1287A polymorphism of SLC6A2 was significantly related to heightened response time variability at baseline in the sustained (P = 2.0 × 10) and auditory selective attention (P = 1.0 × 10) tasks. Response time variability at baseline increased additively with possession of the T allele at the DraI polymorphism of the ADRA2A gene in the auditory selective attention task (P = 2.0 × 10). After medication, increasing possession of a G allele at the MspI polymorphism of the ADRA2A gene was associated with increased MPH-related change in response time variability in the flanker task (P = 1.0 × 10).Our study suggested an association between norepinephrine gene variants and response time variability measured at baseline and after MPH treatment in children with ADHD. Our results add to a growing body of evidence, suggesting that response time variability is a viable endophenotype for ADHD and suggesting its utility as a surrogate end point for measuring stimulant response in pharmacogenetic studies.Keywords
This publication has 31 references indexed in Scilit:
- Noradrenergic genotype predicts lapses in sustained attentionNeuropsychologia, 2009
- Stimulants: Therapeutic Actions in ADHDNeuropsychopharmacology, 2006
- Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugsBMC Pharmacology, 2006
- Attention-deficit hyperactivity disorderThe Lancet, 2005
- Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesBiological Psychiatry, 2003
- The Nature and Heritability of Attention-Deficit/Hyperactivity DisorderChild and Adolescent Psychiatric Clinics of North America, 2001
- Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorderBiological Psychiatry, 1999
- Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integrationBehavioural Brain Research, 1998
- Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life CycleJournal of the American Academy of Child & Adolescent Psychiatry, 1996
- Catecholamines in Attention-Deficit Hyperactivity Disorder: Current PerspectivesJournal of the American Academy of Child & Adolescent Psychiatry, 1996